Oddo BHF Asset Management Sas Makes New $5.16 Million Investment in Astera Labs, Inc. $ALAB

Oddo BHF Asset Management Sas bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 31,033 shares of the company’s stock, valued at approximately $5,163,000.

Several other institutional investors have also made changes to their positions in ALAB. Vanguard Group Inc. lifted its holdings in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares during the last quarter. State Street Corp lifted its holdings in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the last quarter. Morgan Stanley lifted its holdings in Astera Labs by 33.0% during the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after purchasing an additional 480,009 shares during the last quarter. Finally, Amundi lifted its holdings in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This trade represents a 7.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,256 shares of company stock worth $459,844,296 over the last quarter. 10.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Barclays lifted their price target on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Loop Capital assumed coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Needham & Company LLC lifted their price target on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

ALAB opened at $389.20 on Tuesday. The company has a market cap of $66.71 billion, a price-to-earnings ratio of 262.97, a price-to-earnings-growth ratio of 4.86 and a beta of 3.94. The firm has a 50 day simple moving average of $242.61 and a 200 day simple moving average of $180.88. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $398.13.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.